Related Experiment Videos
BRL 38227--a potassium channel opener, antagonizes digoxin-induced convulsions
Y Chugh1, N Saha, A Sankaranarayanan
1Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract:
Experimental evidence suggests that potassium channel openers play an important role in convulsions. In this study, the anticonvulsant activity of BRL 38227, a new potassium channel opener against digoxin-induced convulsions, is reported. Intraventricular administration of digoxin (7.5 micrograms), included "popcorn-type" convulsions in rats. BRL 38227, injected centrally increased the onset time of convulsions and decreased the mortality rate in a dose-dependent manner. Pretreatment with 4-aminopyridine, a potassium channel blocker antagonized the protective effect of BRL 38227. These findings show the involvement of potassium channels in digoxin-induced convulsions. Further these results indicate that in the future potassium channels might be a target for new anticonvulsant drugs.
Insights
Potassium channel openers, like BRL 38227, show anticonvulsant activity against digoxin-induced seizures in rats. This suggests potassium channels are key targets for developing new anti-seizure medications.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Potassium channel openers are implicated in convulsive states.
- Digoxin administration can induce specific seizure types in animal models.
Purpose of the Study:
- To investigate the anticonvulsant potential of BRL 38227, a novel potassium channel opener.
- To explore the role of potassium channels in digoxin-induced convulsions.
Main Methods:
- Intraventricular administration of digoxin to induce convulsions in rats.
- Central administration of BRL 38227 to assess its protective effects.
- Utilizing 4-aminopyridine, a potassium channel blocker, to antagonize BRL 38227's effects.
Main Results:
- BRL 38227 significantly delayed seizure onset and reduced mortality in a dose-dependent manner.
- The protective effects of BRL 38227 were reversed by pretreatment with 4-aminopyridine.
- These findings confirm the involvement of potassium channels in the observed convulsions.
Conclusions:
- Potassium channels play a critical role in digoxin-induced convulsions.
- BRL 38227 demonstrates significant anticonvulsant properties.
- Potassium channels represent a promising therapeutic target for future anticonvulsant drug development.